Tech Company Financing Transactions
Singlera Genomics Funding Round
Singlera Genomics closed a $20 million Series A funding round on 8/24/2016. Investors included Lilly Asia Ventures and private investors.
Transaction Overview
Company Name
Announced On
8/24/2016
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Lilly Asia Ventures (Lead Investor) (Fei Chen)
Proceeds Purpose
The funding will help Singlera expand the development and commercialization of its non-invasive genomic sequencing tests for cancer and other genetic diseases. Singlera will also use the funds to further expand its R&D operations and expedite the launch of new product lines that address tumor diagnosis and personalized treatment.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
505 Coast Blvd. S 309
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Overview
Singlera's main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Johny Zhang
Chief Operating Officer
Qiang Liu
Chief Technical Officer
Rui Liu
Co-Founder
Yuan Gao
Co-Founder
Kun Zhang
Browse more venture capital transactions:
Prev: 8/24/2016: YesVideo venture capital transaction
Next: 8/24/2016: Coda Payments venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs